Concepedia
Statistics
Publications
12
Citations
2K
H-Index
Active since
1987
Affiliations
Memorial Sloan Kettering Cancer Center(Current)
Janssen (United States)
University of California, San Francisco
NewYork–Presbyterian Hospital
Cornell University
Alton B. Kremer is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pharmacology.
Publications per year
1987–2015
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Robert J. Motzer, Thomas E. Hutson, Hilary Glen et al. · The Lancet Oncology · 2015 · 943 citations · Full text
Medicine, Oncology, Pharmacology +14
Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer
J. Zujewski, Ivan D. Horak, C.J. Bol et al. · Journal of Clinical Oncology · 2000 · 265 citations
Medicine, Oncology, Pharmacology +15
Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate Cancer
Paul Sabbatini, Steven M. Larson, Alton B. Kremer et al. · Journal of Clinical Oncology · 1999 · 236 citations
Medicine, Nuclear Medicine, Oncology +17
Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer
Howard I. Scher, W.M. Kelly, Zuo‐Feng Zhang et al. · JNCI Journal of the National Cancer Institute · 1999 · 166 citations · Full text
Medicine, Biostatistics, Oncology +16
Antiviral Activity of Single‐Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV‐Infected Adults
Jeffrey M. Jacobson, Michael S. Saag, Melanie Thompson et al. · The Journal of Infectious Diseases · 2008 · 112 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
1–5 of 12